Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Galapagos Islands -- Ignore unavailable to you. Want to Upgrade?

To: Jorj X Mckie who wrote (14148)	11/23/2002 1:46:01 AM
From: PuddleGlum	Respond to of 57110

I don't know much about CELG other than the fact that they've done quite well with Thalomid. Chart sure looks strong, so I don't wonder why you're looking at it. My long term concern is that I recall that Thalomid has sufficiently negative side effects so that when a good alternative eventually comes along you can figure that use of Thalomid will decline. But maybe by then CELG can push another one or two of its drugs through with the help of the money made on Thalomid. I see lots of similarities between today's charts and those from November 1998. We could be only half way through with the rally, though my system is flashing danger signs right now.